A COMPARISON OF HTA RECOMMENDATIONS ISSUED BY AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT (AHTAPOL) IN POLAND AND THE SCOTTISH MEDICINES CONSORTIUM (SMC)

被引：0
|
作者：
Kolasa, K. [1 ]
机构：
[1] AstraZeneca, Sodertalje, Sweden
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)74223-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A250 / A250
页数：1
相关论文
共 50 条
  • [21] HAVE CHANGES TO THE SCOTTISH MEDICINES CONSORTIUM (SMC) PROCESS FOLLOWING THE ROUTLEDGE REVIEW REALLY IMPROVED ACCESS TO ORPHAN MEDICATIONS AND WHAT FACTORS INFLUENCE RECOMMENDATIONS?
    Marshall, J. D.
    Hill, D.
    Hill, C. A.
    Harries, M.
    VALUE IN HEALTH, 2015, 18 (03) : A93 - A93
  • [22] THE ASSOCIATION BETWEEN EUROPEAN MEDICINES AGENCY APPROVAL AND HEALTH TECHNOLOGY ASSESSMENT RECOMMENDATION
    Lipska, I
    Hoevels, A. M.
    McAuslane, N.
    VALUE IN HEALTH, 2013, 16 (07) : A455 - A455
  • [23] ANALYSIS OF NEUROLOGICAL CONDITIONS SUBMISSIONS TO THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) AND THE SCOTTISH MEDICINES CONSORTIUM (SMC) FROM 2001 TO 2021
    White, A.
    Wong, R.
    Guest, S.
    Carroll, C.
    Essat, M.
    Rowen, D.
    Young, V. J.
    Brazier, J. E.
    VALUE IN HEALTH, 2022, 25 (12) : S314 - S314
  • [24] A COMPARISON OF HEALTH TECHNOLOGY ASSESSMENT (HTA) REQUIREMENTS FOR SYSTEMATIC LITERATURE REVIEWS (SLRS)
    Sarnes, E.
    Cadarette, S. M.
    Sawchyn, B.
    Gittings, K.
    Kulp, W.
    Siu, E. C.
    Ruiz, K.
    Wissinger, E.
    VALUE IN HEALTH, 2017, 20 (09) : A698 - A698
  • [25] THE ROLE OF ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS IN WORKS AND RECOMMENDATIONS OF AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT IN POLAND (AOTM) IN YEARS 2005-2011
    Ofierska-Sujkowska, G.
    Matusewicz, W.
    Jagodzinska-Kalinowska, K.
    VALUE IN HEALTH, 2012, 15 (07) : A619 - A619
  • [26] Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland
    Allen, Nicola
    Walker, Stuart R.
    Liberti, Lawrence
    Salek, Sam
    VALUE IN HEALTH, 2017, 20 (03) : 320 - 328
  • [27] Driving factors and mode transformation regarding health technology assessment (HTA) in China: Problems and recommendations
    Wang, Haiyin
    Jin, Chunlin
    Bai, Fei
    Lin, Xia
    Fang, Liang
    Sun, Hui
    Cheng, Wendi
    Song, Peipei
    BIOSCIENCE TRENDS, 2019, 13 (02) : 110 - 116
  • [28] REVIEW OF THE RECOMMENDATIONS MADE BY THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) AND THE SCOTTISH MEDICIAL CONSORTIUM (SMC) RELATING TO TREATMENTS FOR RARE DISEASES
    Sanchez, Garcia J. J.
    Hill, C. A.
    VALUE IN HEALTH, 2016, 19 (07) : A489 - A489
  • [29] NICE guidance: a comparative study of the introduction of the single technology appraisal process and comparison with guidance from Scottish Medicines Consortium
    Ford, John A.
    Waugh, Norman
    Sharma, Pawana
    Sculpher, Mark
    Walker, Andrew
    BMJ OPEN, 2012, 2 (01):
  • [30] HEALTH TECHNOLOGY ASSESSMENT IN POLAND AND SCOTLAND: COMPARISON OF PROCESS AND DECISIONS
    Kolasa, Katarzyna
    Wasiak, Radek
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012, 28 (01) : 70 - 76
12345